Impact of Type of Hypomethylating Agent (HMA) Used on Outcomes of Patients (Pts) with Higher-Risk Myelodysplastic Syndromes/Neoplasms (HR-MDS) - a Large, Multicenter, Retrospective Analysis Philipp Bewersdorf , Tariq Kewan , Ondrej Blaha , Maximilian Stahl , Najla H. Al Ali , Amy E. DeZern , Mikkael A. Sekeres , Geoffrey L. Uy , Hetty E. Carraway , Pinkal Desai , Elizabeth A. Griffiths , Eytan M. Stein , Andrew M. Brunner , Christine M. McMahon , Joshua F. Zeidner , Michael R. Savona , Jessica M. Stempel , Namrata Sonia Chandhok , Rahul Ramaswamy , Gail J. Roboz , Benjamin Rolles , Eunice S. Wang , Amyah C. Harris , Maria L. Amaya , Hayley Hawkins , Justin Grenet , Carmelo Gurnari , Rory M. Shallis , Zhuoer Xie , Jaroslaw P. Maciejewski , David A. Sallman , Matteo Giovanni Della Porta , Rami S. Komrokji , Amer M. Zeidan BLOOD（2023）
AI 理解论文
溯源树
样例
